The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives

@article{Tonyali2010TheRO,
  title={The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives},
  author={Onder Tonyali and C. Ceyhun Arslan and Kadri Altundag},
  journal={Expert Opinion on Pharmacotherapy},
  year={2010},
  volume={11},
  pages={2715 - 2725}
}
  • Onder Tonyali, C. Ceyhun Arslan, Kadri Altundag
  • Published 2010
  • Medicine
  • Expert Opinion on Pharmacotherapy
  • Importance of the field: Breast cancer is one of the leading causes of cancer-related deaths in the world. Despite the significant improvements in the adjuvant treatment strategies of early-stage breast cancer, many patients experience relapse. Bisphosphonates are widely used in the treatment of bone metastasis of solid tumors and multiple myeloma, as well as in osteoporosis. The results of clinical studies of adjuvant treatment on early-stage hormone-receptor-positive breast-cancer patients… CONTINUE READING

    Paper Mentions

    BLOG POST

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 10 CITATIONS

    Bisphosphonates: Focus on Inflammation and Bone Loss

    VIEW 1 EXCERPT
    CITES BACKGROUND

    GPR55: a new promising target for metabolism?

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 81 REFERENCES